Simon Grime, of Wilmington Healthcare, explains how pharma can navigate the new integrated care landscape using an intelligence-led approach
Simon Grime, of Wilmington Healthcare, explains how pharma can navigate the new integrated care landscape using an intelligence-led approach
Janssen believes RWE could realise an efficient, personalised and truly patient-centric healthcare system
Tom O’Leary considers how the Internet of Medical Things (IoMT) is evolving the patient role in pharma
New smart building technologies are helping pharmaceutical companies enhance productivity without compromising on compliance or quality. However, to maximise the available opportunities, companies need to choose the right technology providers, explains Adam Chapman, Vertical Sales Director – Life Sciences (Europe) at Honeywell Building Solutions.
As many as 500 million patients worldwide are suffering from a ‘rare’ disease. This evolving landscape is a growing concern for payers, say Adelphi Values | PROVE
Future commercial models will see radical reorganisation in the coming years
How can big pharma and SME pharma work to mutual advantage and help patients with unmet medical need?
Richard Billington, chief technology officer of MatsSoft, explains how IT leaders can adapt to a patient-centric world
Sam Grove, commercial director at Oberoi Consulting, explains how pharma companies can better achieve their brand objectives with training on clinical systems intelligence.
Label – and label extension – strategy is starting to shift from a broader and broader focus to a very specific one
Ashfield wants to change the perception of CSOs and their role within pharma
The one consistent theme in today’s market place is complexity
Many of us recognise that we need others’ knowledge to address the opportunities and challenges we face, yet we still lack the time or motivation to collaborate
The connectivity made possible by the Internet of Things (IoT) has provided new opportunities for businesses to put their buildings to work and reap the rewards
Uncertainty and new technologies require new thinking